Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Hydronopol derivatives as agonists on human ORL1 receptors

Hydronopol derivatives as agonists on human ORL1 receptors

US Patent 7241770 · Granted Jul 10, 2007

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of SGLT-2 inhibitors in the drying-off of non-human mammals2025
Treatment of metabolic disorders in feline animals2024
Use of SGLT-2 inhibitors in the drying-off of non-human mammals2023
Maresins for use in the treatment of CNS injuries2023
Treatment of metabolic disorders in canine animals2022
Modular antigen transportation molecules and uses therof2021
Modular antigen transportation molecules and uses thereof in animals2021
Treatment of metabolic disorders in equine animals2020
Treatment of metabolic disorders in equine animals2020
Treatment of metabolic disorders in feline animals2020
Treatment of metabolic disorders in canine animals2020
Combination treatment of SGLT2 inhibitors and dopamine agonists for preventing m2020